Atrás
Rango del Día
$9.43
$9.99
Rango de 52 Semanas
$9.23
$28.44
Volumen
2,496,293
Promedio 50D / 200D
$13.28
/
$19.16
Cierre Anterior
$9.64
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -0.9 | 0.2 |
| P/B | 0.5 | 3.0 |
| ROE % | -39.3 | 3.6 |
| Net Margin % | -33.5 | 3.8 |
| Rev Growth 5Y % | 0.7 | 9.9 |
| D/E | 1.4 | 0.2 |
Precio Objetivo de Analistas
Hold
$21.50
+121.9%
Low: $20.00
High: $23.00
P/E Futuro
4.25
EPS Futuro
$2.28
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
4.13B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$2.92
$2.90 – $2.95
|
4.26B | 1 |
| FY2029 |
$2.82
$2.80 – $2.85
|
4.21B | 1 |
| FY2028 |
$2.67
$2.64 – $2.69
|
4.20B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | $0.78 | $0.77 | -1.8% |
| 2025-11-05 | $0.75 | $0.80 | +6.7% |
| 2025-08-06 | $0.59 | $0.57 | -3.4% |
| 2025-05-07 | $0.56 | $0.60 | +7.1% |
| 2025-02-27 | $0.92 | $0.93 | +1.1% |
| 2024-11-06 | $0.82 | $0.81 | -1.2% |
| 2024-08-02 | $0.48 | $0.53 | +10.4% |
| 2024-05-07 | $0.24 | $0.29 | +20.8% |
Dividend History
7 yr streakYield
0.08%
Payout Ratio
-0.11%
Growth (3Y)
3.71%
Growth (5Y)
5.21%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 02, 2026 | Mar 24, 2026 | $0.29 | 9.40% |
| Nov 28, 2025 | Dec 16, 2025 | $0.29 | 8.69% |
| Aug 29, 2025 | Sep 16, 2025 | $0.29 | 4.83% |
| May 30, 2025 | Jun 17, 2025 | $0.29 | 4.23% |
| Mar 07, 2025 | Mar 25, 2025 | $0.29 | 4.03% |
| Nov 29, 2024 | Dec 17, 2024 | $0.28 | 3.87% |
| Aug 30, 2024 | Sep 17, 2024 | $0.28 | 3.78% |
| May 31, 2024 | Jun 18, 2024 | $0.28 | 3.99% |
| Mar 07, 2024 | Mar 26, 2024 | $0.28 | 3.69% |
| Nov 30, 2023 | Dec 19, 2023 | $0.27 | 3.59% |
| Aug 31, 2023 | Sep 19, 2023 | $0.27 | 3.08% |
| Jun 01, 2023 | Jun 20, 2023 | $0.27 | 3.33% |
| Mar 09, 2023 | Mar 28, 2023 | $0.27 | 2.90% |
| Dec 01, 2022 | Dec 20, 2022 | $0.26 | 3.24% |
| Sep 01, 2022 | Sep 20, 2022 | $0.26 | 2.77% |
| Jun 02, 2022 | Jun 21, 2022 | $0.26 | 2.52% |
| Feb 25, 2022 | Mar 17, 2022 | $0.26 | 2.75% |
| Dec 02, 2021 | Dec 21, 2021 | $0.24 | 2.68% |
| Sep 02, 2021 | Sep 21, 2021 | $0.24 | 2.28% |
| Jun 03, 2021 | Jun 22, 2021 | $0.24 | 1.96% |
Puntos Clave
Revenue grew 0.68% annually over 5 years — modest growth
Generating 145.10M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.43%
Capital efficient — spends only 2.20% of revenue on capex
ROIC of 3.73% — low return on invested capital
Dividends growing 5.21% annually over 5 years
Crecimiento
Revenue Growth (5Y)
0.68%
Revenue (1Y)-2.75%
Earnings (1Y)N/A
FCF Growth (3Y)-30.89%
Calidad
Return on Equity
-39.29%
ROIC3.73%
Net Margin-33.51%
Op. Margin8.07%
Seguridad
Debt / Equity
1.35
Current Ratio2.76
Interest Coverage2.11
Valoración
P/E Ratio
-0.94
Forward P/E4.25
P/B Ratio0.45
EV/EBITDA13.90
Dividend Yield0.08%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.75% | Revenue Growth (3Y) | -4.42% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0.68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.25B | Net Income (TTM) | -1.43B |
| ROE | -39.29% | ROA | -16.70% |
| Gross Margin | 35.14% | Operating Margin | 8.07% |
| Net Margin | -33.51% | Free Cash Flow (TTM) | 145.10M |
| ROIC | 3.73% | FCF Growth (3Y) | -30.89% |
| Safety | |||
| Debt / Equity | 1.35 | Current Ratio | 2.76 |
| Interest Coverage | 2.11 | ||
| Dividends | |||
| Dividend Yield | 0.08% | Payout Ratio | -0.11% |
| Dividend Growth (3Y) | 3.71% | Dividend Growth (5Y) | 5.21% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | -0.94 | Forward P/E | 4.25 |
| P/B Ratio | 0.45 | P/S Ratio | 0.31 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | 13.90 | Fwd EV/EBITDA | 21.22 |
| Forward P/S | 0.32 | Fwd Earnings Yield | 23.53% |
| FCF Yield | 10.88% | ||
| Market Cap | 1.33B | Enterprise Value | 4.77B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.25B | 4.37B | 4.66B | 4.45B | 4.14B |
| Net Income | -1.43B | -171.80M | -12.70M | -140.60M | -68.90M |
| EPS (Diluted) | -10.29 | -1.25 | -0.09 | -0.97 | -0.98 |
| Gross Profit | 1.49B | 1.54B | 1.68B | 1.46B | 1.42B |
| Operating Income | 343.30M | 112.90M | 151.90M | 78.90M | 410.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.54B | 9.65B | 10.81B | 11.02B | 10.43B |
| Total Liabilities | 5.60B | 5.33B | 6.04B | 6.18B | 5.27B |
| Shareholders' Equity | 2.94B | 4.32B | 4.77B | 4.84B | 5.15B |
| Total Debt | 3.97B | 3.62B | 4.07B | 4.32B | 3.69B |
| Cash & Equivalents | 531.60M | 558.80M | 751.30M | 600.70M | 1.86B |
| Current Assets | 2.80B | 2.48B | 2.83B | 2.72B | 3.86B |
| Current Liabilities | 1.01B | 1.04B | 1.59B | 1.11B | 1.59B |